Sari Fishman
Corporate Officer/Principal chez CAN-FITE BIOPHARMA LTD.
Fortune : - $ au 31/03/2024
Profil
Sari Fishman is a professional with a background in business development and clinical affairs.
She is currently working as the Vice President of Business Development at Can-Fite BioPharma Ltd.
She started this position in 2017.
Previously, she worked as the Director of Clinical Affairs at OphthaliX, Inc. Dr. Fishman holds a doctorate degree from Bar-Ilan University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Sari Fishman
Sociétés | Poste | Début |
---|---|---|
CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01/01/2014 |
Anciens postes connus de Sari Fishman
Sociétés | Poste | Fin |
---|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Tech/Sci/R&D Officer | - |
Formation de Sari Fishman
Bar-Ilan University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CAN-FITE BIOPHARMA LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |